Paratek Pharmaceuticals News and Activities

Paratek Pharmaceuticals is a company listed under the stock ticker PRTK (US).

Acquisition, funding and merger involving Paratek Pharmaceuticals.

• Paratek Pharmaceuticals has acquired OptiNose (posted on June 25 2025).

View the org chart displaying its 30 main executives

Most searched biographies at Paratek Pharmaceuticals

• Evan Loh, Chief Executive Officer and Director
• Aleks Engel, Director
• Nithya Desikan, Director

Create your alert
to follow the executive moves at Paratek Pharmaceuticals.

Paratek Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Paratek Pharmaceuticals

• Paratek Pharma | Press Release
• Paratek Pharma | Press Release
• Paratek Pharma | Press Release
• Paratek Pharma | Press Release
• Paratek Pharma | Press Release
• Paratek Pharma | Press Release
• Paratek Pharma | Press Release
• Paratek Pharma | Press Release
• Paratek Pharma | Press Release
• Paratek Pharma | Press Release
• View more press releases Close

Social media about Paratek Pharmaceuticals

• Paratek Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Paratek Pharmaceuticals on LinkedIn, X (Twitter) & YouTube